Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

A Big Surge in This "Bird Flu" Biotech

Biotechs continue to be hot.

If you own the right ones, that is ...

Shares of Inovio Pharmaceuticals Inc. (NYSE: INO), a synthetic-vaccine player we recommended back on Feb. 1, soared as much as 19% yesterday after the Blue Bell, Pa.-based biotech said that its universal H7N9 DNA Vaccine protected 100% of vaccinated animals in a challenge study.

To continue reading, please click here...

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK